Category

UF COVID-19

SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.

UF Health Discovers Possible Risk Factor for COVID-19

A UF research team found vitamin D-deficient patients were four times more likely to be COVID-19 positive than those with a sufficient amount of the crucial vitamin, which people can get from sources like sunlight and animal proteins.